Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20518-22. doi: 10.1073/pnas.1014557107. Epub 2010 Nov 1.

Abstract

Cognitive decline following surgery in older individuals is a major clinical problem of uncertain mechanism; a similar cognitive decline also follows severe infection, chemotherapy, or trauma and is currently without effective therapy. A variety of mechanisms have been proposed, and exploring the role of inflammation, we recently reported the role of IL-1β in the hippocampus after surgery in mice with postoperative cognitive dysfunction. Here, we show that TNF-α is upstream of IL-1 and provokes its production in the brain. Peripheral blockade of TNF-α is able to limit the release of IL-1 and prevent neuroinflammation and cognitive decline in a mouse model of surgery-induced cognitive decline. TNF-α appears to synergize with MyD88, the IL-1/TLR superfamily common signaling pathway, to sustain postoperative cognitive decline. Taken together, our results suggest a unique therapeutic potential for preemptive treatment with anti-TNF antibody to prevent surgery-induced cognitive decline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cognition Disorders / etiology*
  • Cognition Disorders / immunology
  • Cytokines / metabolism
  • Cytokines / toxicity*
  • Enzyme-Linked Immunosorbent Assay
  • HMGB1 Protein / metabolism
  • Inflammation / complications*
  • Inflammation / etiology
  • Interleukin-1 / metabolism*
  • Mice
  • Mice, Knockout
  • Myeloid Differentiation Factor 88 / metabolism
  • Postoperative Complications / immunology*
  • Signal Transduction / immunology*
  • Toll-Like Receptor 4 / genetics
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Cytokines
  • HMGB1 Protein
  • Interleukin-1
  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha